Biomm S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was BRL 118.19 million compared to BRL 104.95 million a year ago. Net loss was BRL 81.14 million compared to BRL 92.56 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.62 BRL | -4.52% | -1.51% | +170.24% |
18/04 | Biocon Signs Licensing and Supply Pact with Biomm to Commercialize Generic Ozempic in Brazil | MT |
17/04 | Biocon Limited Signs an Exclusive Licensing and Supply Agreement with Biomm S.A | CI |
1st Jan change | Capi. | |
---|---|---|
+170.24% | 274M | |
+9.58% | 115B | |
+12.41% | 106B | |
-2.59% | 21.96B | |
-12.38% | 21.87B | |
-5.29% | 19.21B | |
-3.35% | 18.08B | |
-38.57% | 17.71B | |
+7.51% | 14.32B | |
+35.67% | 12.42B |
- Stock Market
- Equities
- BIOM3 Stock
- News Biomm S.A.
- Biomm S.A. Reports Earnings Results for the Full Year Ended December 31, 2023